Expression and potential immune involvement of cuproptosis in kidney renal clear cell carcinoma

被引:25
作者
Liu, Hengrui [1 ]
机构
[1] Tianjin Yinuo Biomed Co Ltd, 1 Shuchang Pk,Wanxin St, Tianjin, Peoples R China
关键词
Cuproptosis; KIRC; Genes; Immunotherapy;
D O I
10.1016/j.cancergen.2023.03.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cuproptosis is a newly identified programmed cell death pathway mediated by intracellular free copper. Cuproptosis genes were studied in this study for a better insight into the role of cuproptosis in cancers. The analysis identified kidney renal clear cell carcinoma (KIRC) as a cancer type most likely to be affected by cuproptosis. This study analyzed the multi-omic data to explore the cancer-noncancer expression pattern and potential immune involvement of the cuproptosis pathway in KIRC. This study clustered the TCGA KIRC samples based on the gene set of 12 cuproptosis genes to study the role of cuproptosis in the KIRC immune microenvironment and found the potential value of cuproptosis signature for immunotherapy prognosis. This study concluded that cuproptosis might affect KIRC and had potential application value in immune therapy. Hopefully, this study can contribute to the application of cuproptosis in the clinical therapy of KIRC.& COPY; 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:21 / 25
页数:5
相关论文
共 50 条
  • [31] Multi-omics analysis uncovers clinical, immunological, and pharmacogenomic implications of cuproptosis in clear cell renal cell carcinoma
    Zhu, Maoshu
    Li, Yongsheng
    Wang, Yun
    Lin, Pingli
    Mi, Jun
    Zhong, Weimin
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [32] Characterization of cuproptosis signature in clear cell renal cell carcinoma by single cell and spatial transcriptome analysis
    Zou, Xiaohong
    Liu, Xiaoqing
    Wang, Huiting
    Li, Zhenhua
    Zhou, Chen
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [33] Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma
    Xie, Tongjin
    Liu, Bin
    Liu, Dongbo
    Zhou, Yusong
    Yang, Qingping
    Wang, Dai
    Tang, Mengjie
    Liu, Wei
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [34] Multi-omics analysis uncovers clinical, immunological, and pharmacogenomic implications of cuproptosis in clear cell renal cell carcinoma
    Maoshu Zhu
    Yongsheng Li
    Yun Wang
    Pingli Lin
    Jun Mi
    Weimin Zhong
    European Journal of Medical Research, 28
  • [35] Identification of anoikis-related subtypes and immune landscape in kidney renal clear cell carcinoma
    Ding, Wencong
    Zhang, Min
    Zhang, Ping
    Zhang, Xianghong
    Sun, Junwei
    Lin, Biying
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [36] Molecular Subtyping Based on Cuproptosis-Related Genes and Characterization of Tumor Microenvironment Infiltration in Kidney Renal Clear Cell Carcinoma
    Ji, Zhong-Hao
    Ren, Wen-Zhi
    Wang, Hao-Qi
    Gao, Wei
    Yuan, Bao
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [37] Diagnostic and prognostic potential of FBXO8 expression in kidney renal clear cell carcinoma and its regulation of renal adenocarcinoma cells
    Luo, Zhouan
    Wu, Xiaoping
    Xie, Juanxia
    Tang, Hao
    Chen, Jingqi
    Ye, Dongcai
    Dou, Shangwen
    Chen, Songning
    CANCER GENETICS, 2025, 290 : 6 - 15
  • [38] ACSL3 is a potential prognostic biomarker for immune infiltration in clear cell renal cell carcinoma
    Zhang, Chiyu
    Hu, Honglin
    Huang, Ruizhen
    Huang, Gaomin
    Xi, Xiaoqing
    FRONTIERS IN SURGERY, 2022, 9
  • [39] Cuproptosis-related lncRNA: Prediction of prognosis and subtype determination in clear cell renal cell carcinoma
    Huili, Youlong
    Nie, Shiwen
    Zhang, Liguo
    Yao, Anliang
    Liu, Jian
    Wang, Yong
    Wang, Lei
    Cao, Fenghong
    FRONTIERS IN GENETICS, 2022, 13
  • [40] Circadian clock is associated with tumor microenvironment in kidney renal clear cell carcinoma
    Zhou, Liangcheng
    Luo, Zhili
    Li, Zuwei
    Huang, Qinying
    AGING-US, 2020, 12 (14): : 14620 - 14632